Passport of sensitization of schoolchildren as a tool for the prevention of asthma

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


Molecular allergy diagnosis allows to identify sensitization to a large range of respiratory allergens, which is important in the diagnosis of allergic asthma. Moreover, based on the reactive IgE profile detected at an early age, it is possible to predict the development of allergic respiratory diseases even at the preclinical stage. The goal of the pilot project was to create a children's passport sensitization using a multiplex panel to be able to identify groups at risk for the development of asthma in children of early school age. Materials and methods. Parents of 33 students studying in the second grade of the Tashkent gymnasium were questioned using the ISAAC questionnaire for the clinical manifestations of respiratory diseases in their children. Their children’s sera were tested for the presence of IgE to various allergenic molecules using the MeDALL research method. Results. 30% of children were sensitized to at least one allergen, and 30% of them were born by Caesarean section. and 30% of them were born by Caesarean section. In total, 68 of the 176 allergenic molecules located on the MeDALL microchip were recognized. 80% of sensitized children had a genuine polysensitization to 3 or more major allergens. In 18% of children, IgE to household molecules of the risk of developing asthma, such as Alt a 1, Bla g 1, Bla g 2, Can f 1, Fel d 1, were detected. Conclusions. In general, clinical manifestations in the form of wheezing and obstruction were detected in 60% of sensitized children, but only 40% of these children were under the supervision of an allergist or received symptomatic treatment. In 20% of already sensitized children, clinical symptoms were absent. Molecular testing of the profile of IgE sensitization and the creation of an allergic passport allows us to identify a group of children at risk for developing asthma. This information can be used to assign therapy and secondary prevention of asthma in the early school years.

Restricted Access

G S Dzhambekova

International Center for Molecular Allergology of Ministry of Innovative of the RUz

Email: djambekovagul@yandex.ru

S Petros Katsamaki

International Center for Molecular Allergology of Ministry of Innovative of the RUz

V F Garib

Medical University of Vienna

  1. Garib V, Wollmann E, Djambekova G, Lemell P, Kmenta M, Berger U, Zieglmayer P, Valenta R. Possible effect of landscape design on IgE recognition profiles of two generations revealed with micro-arrayed allergens. Allergy. 2017;72:1579-1582. doi: 10.1111/all.13169.
  2. Karaulov AV, Garib V, Garib F, Valenta R. Protein Biomarkers in Asthma. International Archives of Allergy and Immunology. 2018;175:189-208. doi: 10.1159/000486856.
  3. Lupinek C et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods. 2014;66:106-119. DOI: 10.1016/j. ymeth.2013.10.008.
  4. Zissler UM, Esser-von Bieren J, Jakwerth CA, Chaker AM, Schmidt-Weber CB. Current and future biomarkers in allergic asthma. Allergy. 2016;71:475-494. doi: 10.1111/all.12828.
  5. Sastre-Ibanez M, Sastre J. Molecular allergy diagnosis for the clinical characterization of asthma. Expert Review of Molecular Diagnostics 2015;15:789-799. doi: 10.1586/14737159. 2015.1036745.
  6. Curin M, Garib V, Valenta R. Single recombinant and purified major allergens and peptides: How they are made and how they change allergy diagnosis and treatment. Annals of Allergy, Asthma & Immunology. 2017;119:201-209. DOI: 10.1016/j. anai.2016.11.022.
  7. Posa D, Perna S, Resch Y, Lupinek C, Panetta V, Hofmaier S, Rohrbach A, Hatzler L, Grabenhenrich L, Tsilochristou O, Chen KW, Bauer CP, Hoffman U, Forster J, Zepp F, Schuster A, Wahn U, Keil T, Lau S, Vrtala S, Valenta R, Matri-cardi PM. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens-during the first 2 decades of life. The Journal of Allergy and Clinical Immunology. 2017;139:541-549. DOI: 10.1016/j. jaci.2016.08.014.
  8. Simpson A, Lazic N, Belgrave D, Johnson P, Bishop C, Mills C, Custovic A. Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years. The Journal of Allergy and Clinical Immunology. 2015;136:1224-1231. doi: 10.1016/j.jaci.2015.03.027.
  9. Chen CH, Chao HJ, Chan CC, Chen BY, Guo YL. Current asthma in schoolchildren is related to fungal spores in classrooms. Chest. 2014;146:123-134. DOI: 10.1378/ chest.13-2129.
  10. Gergen PJ, Mitchell HE, Calatroni A, Sever ML, Cohn RD, Salo PM, Thorne PS, Zeldin DC. Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population. The Journal of Allergy and Clinical Immunology In Practice. 2018;6:101-107. doi: 10.1016/.2017.05.019.
  11. Weghofer M, Grote M, Resch Y, Casset A, Kneidinger M, Kopec J, Thomas WR, Fernandez-Caldas E, Kabesch M, Ferrara R, Mari A, Purohit A, Pauli G, Horak F, Keller W, Valent P, Valenta R, Vrtala S.: Identification of Der p 23, a Peritrophin-like Protein, as a New Major Dermatophagoides pteronyssinus Allergen Associated with the Peritrophic Matrix of Mite Fecal Pellets. Journal of Immunology. 2013;190:3059-3067. doi: 10.4049/jimmunol.1202288.
  12. Santos da Silva E, Asam C, Lackner P, Hofer H, Wallner M, Silva Pinheiro C, Alcantara-Neves NM, Ferreira F. Allergens of Blomia tropicalis: An Overview of Recombinant Molecules. International Archives of Allergy and Immunology. 2017;172:203-214. doi: 10.1159/000464325.
  13. Do DC, Zhao Y, Gao P. Cockroach allergen exposure and risk of asthma. Allergy. 2016;71:463-474. doi: 10.1111/all.12827.
  14. Sharpe RA, Bearman N, Thornton CR, Husk K, Osborne NJ. Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. The Journal of Allergy and Clinical Immunology. 2015;135:110-122. DOI: 10.1016/j. jaci.2014.07.002.

Views

Abstract - 33

PDF (Russian) - 0

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2019 Russian Allergological Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies